- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Remab Pharmaceuticals Private Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (75), financial health (60), director (95) and company-foundation signals.
- Operating for 13+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2019 - filings look overdue.
- Profitable in FY 2020.
- Positive net worth.
- 2 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Remab Pharmaceuticals Private Limited
Remab Pharmaceuticals Private Limited is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U24100WB2013PTC190819). Business overview includes Pharma (Pharmaceutical Retailers & Distributors), incorporated on February 21, 2013 (13+ years old), headquartered in Kolkata, West Bengal, India. The company is currently Active with Active Compliant compliance status.
- Location 3/2/F/1, Prafulla Chaki Road, Baranagar,, Kolkata, West Bengal - 700036
- Website remabpharma.com
Financial Performance of Remab Pharmaceuticals Private Limited
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Remab Pharmaceuticals Private Limited (2)
Charges of Remab Pharmaceuticals Private Limited
| Lender | Amount | Status |
|---|---|---|
|
Indian Bank
Creation Date: 21 May 2018 |
21.70 Lakh | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Hospital and Medical Care | - | 100 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
